Literature DB >> 25443285

Rescue of impaired late-phase long-term depression in a tau transgenic mouse model.

Tariq Ahmed1, David Blum2, Sylvie Burnouf3, Dominique Demeyer4, Valérie Buée-Scherrer2, Rudi D'Hooge1, Luc Buée2, Detlef Balschun5.   

Abstract

Cognitive decline, the hallmark of Alzheimer's disease, and accompanying neuropsychiatric symptoms share dysfunctions of synaptic processes as a common cellular pathomechanism. Long-term potentiation has proven to be a sensitive tool for the "diagnosis" of such synaptic dysfunctions. Much less, however, is known about how long-term depression (LTD), an alternative mechanism for the storage of memory, is affected by Alzheimer's disease progression. Here, we demonstrate that impaired late LTD (>3 hours) in THY-Tau22 mice can be rescued by either inhibition of glycogen synthase kinase-3 (GSK3β) activity or by application of the protein-phosphatase 2A agonist selenate. In line with these findings, we observed increased phosphorylation of GSK3β at Y216 and reduced total phosphatase activity in biochemical assays of hippocampal tissue of THY-Tau22 mice. Interestingly, LTD induction and pharmacologic inhibition of GSK3β appeared to downregulate GSK3ß activity via a marked upregulation of phosphorylation at the inhibitory Ser9 residue. Our results point to alterations in phosphorylation and/or dephosphorylation homeostasis as key mechanisms underlying the deficits in LTD and hippocampus-dependent learning found in THY-Tau22 mice.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; CA1-region; Glycogen synthase kinase-3; Hippocampus; LTD; Long-term depression; Okadaic acid; Protein-phosphatase 2A; SB216763; Sodium selenate; Synaptic plasticity; Tauopathy

Mesh:

Substances:

Year:  2014        PMID: 25443285     DOI: 10.1016/j.neurobiolaging.2014.09.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  14 in total

1.  Dynamic SAP102 expression in the hippocampal subregions of rats and APP/PS1 mice of various ages.

Authors:  Dongning Su; Hui Liu; Tianrong Liu; Xin Zhang; Wei Yang; Yizhi Song; Jinping Liu; Yan Wu; Lirong Chang
Journal:  J Anat       Date:  2018-03-25       Impact factor: 2.610

2.  AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo.

Authors:  Manon Domise; Sébastien Didier; Claudia Marinangeli; Haitian Zhao; Pallavi Chandakkar; Luc Buée; Benoit Viollet; Peter Davies; Philippe Marambaud; Valérie Vingtdeux
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

3.  Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.

Authors:  Kesava Asam; Agnieszka Staniszewski; Hong Zhang; Scott L Melideo; Adolfo Mazzeo; Michael Voronkov; Kristen L Huber; Eduardo Pérez; Maxwell Stock; Jeffry B Stock; Ottavio Arancio; Russell E Nicholls
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

4.  Tau deletion promotes brain insulin resistance.

Authors:  Elodie Marciniak; Antoine Leboucher; Emilie Caron; Tariq Ahmed; Anne Tailleux; Julie Dumont; Tarik Issad; Ellen Gerhardt; Patrick Pagesy; Margaux Vileno; Clément Bournonville; Malika Hamdane; Kadiombo Bantubungi; Steve Lancel; Dominique Demeyer; Sabiha Eddarkaoui; Emmanuelle Vallez; Didier Vieau; Sandrine Humez; Emilie Faivre; Benjamin Grenier-Boley; Tiago F Outeiro; Bart Staels; Philippe Amouyel; Detlef Balschun; Luc Buee; David Blum
Journal:  J Exp Med       Date:  2017-06-26       Impact factor: 14.307

5.  Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.

Authors:  Yan-Shi Hu; Juncai Xin; Ying Hu; Lei Zhang; Ju Wang
Journal:  Alzheimers Res Ther       Date:  2017-04-27       Impact factor: 6.982

6.  Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy.

Authors:  Cyril Laurent; Guillaume Dorothée; Stéphane Hunot; Elodie Martin; Yann Monnet; Marie Duchamp; Yuan Dong; François-Pierre Légeron; Antoine Leboucher; Sylvie Burnouf; Emilie Faivre; Kévin Carvalho; Raphaëlle Caillierez; Nadège Zommer; Dominique Demeyer; Nathalie Jouy; Veronique Sazdovitch; Susanna Schraen-Maschke; Cécile Delarasse; Luc Buée; David Blum
Journal:  Brain       Date:  2016-11-05       Impact factor: 13.501

7.  Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors.

Authors:  Mariana Temido-Ferreira; Diana G Ferreira; Vânia L Batalha; Inês Marques-Morgado; Joana E Coelho; Pedro Pereira; Rui Gomes; Andreia Pinto; Sara Carvalho; Paula M Canas; Laetitia Cuvelier; Valerie Buée-Scherrer; Emilie Faivre; Younis Baqi; Christa E Müller; José Pimentel; Serge N Schiffmann; Luc Buée; Michael Bader; Tiago F Outeiro; David Blum; Rodrigo A Cunha; Hélène Marie; Paula A Pousinha; Luísa V Lopes
Journal:  Mol Psychiatry       Date:  2018-06-27       Impact factor: 15.992

Review 8.  A walk through tau therapeutic strategies.

Authors:  Santosh Jadhav; Jesus Avila; Michael Schöll; Gabor G Kovacs; Enikö Kövari; Rostislav Skrabana; Lewis D Evans; Eva Kontsekova; Barbara Malawska; Rohan de Silva; Luc Buee; Norbert Zilka
Journal:  Acta Neuropathol Commun       Date:  2019-02-15       Impact factor: 7.801

9.  Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway.

Authors:  Yan-Juan Wang; Qing-Guo Ren; Wei-Gang Gong; Di Wu; Xiang Tang; Xiao-Li Li; Fang-Fang Wu; Feng Bai; Lin Xu; Zhi-Jun Zhang
Journal:  Oncotarget       Date:  2016-03-22

10.  Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator.

Authors:  Snehajyoti Chatterjee; Raphaelle Cassel; Anne Schneider-Anthony; Karine Merienne; Brigitte Cosquer; Laura Tzeplaeff; Sarmistha Halder Sinha; Manoj Kumar; Piyush Chaturbedy; Muthusamy Eswaramoorthy; Stéphanie Le Gras; Céline Keime; Olivier Bousiges; Patrick Dutar; Petnoi Petsophonsakul; Claire Rampon; Jean-Christophe Cassel; Luc Buée; David Blum; Tapas K Kundu; Anne-Laurence Boutillier
Journal:  EMBO Mol Med       Date:  2018-11       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.